| review article | Q7318358 |
| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P50 | author | Antonio C. Wolff | Q38524069 |
| P2093 | author name string | H-C Yeh | |
| F L Brancati | |||
| M A Carducci | |||
| K B Stein | |||
| B B Barone | |||
| C F Snyder | |||
| K S Peairs | |||
| R L Derr | |||
| P2860 | cites work | Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis | Q27860511 |
| History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States). | Q31002293 | ||
| Insulin-like growth factors and prostate cancer | Q33715198 | ||
| An evaluation of radical prostatectomy at Veterans Affairs Medical Centers: time trends and geographic variation in utilization and outcomes | Q33753068 | ||
| Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis | Q34976375 | ||
| Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis | Q36710824 | ||
| The type I insulin-like growth factor receptor pathway: a key player in cancer therapeutic resistance | Q37175061 | ||
| Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities | Q37199217 | ||
| Diabetes mellitus: a predictor for late radiation morbidity | Q39489072 | ||
| The burden and treatment of diabetes in elderly individuals in the u.s. | Q40275706 | ||
| Delayed activation of insulin-like growth factor-1 receptor/Src/MAPK/Egr-1 signaling regulates clusterin expression, a pro-survival factor. | Q40462263 | ||
| Serum-free growth of adult human prostatic epithelial cells | Q42486678 | ||
| Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02. | Q43166284 | ||
| The impact of primary Gleason grade on biochemical outcome following brachytherapy for hormone-naive Gleason score 7 prostate cancer | Q44912498 | ||
| Preoperative cardiopulmonary risk assessment as predictor of early noncancer and overall mortality after radical prostatectomy | Q44913406 | ||
| Primary Gleason pattern does not impact survival after permanent interstitial brachytherapy for Gleason score 7 prostate cancer | Q44929926 | ||
| Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer | Q46769210 | ||
| Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index: clinical correlates of prostate volume among Black men. | Q46816917 | ||
| Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. | Q51486594 | ||
| The development and validation of a comorbidity index for prostate cancer among Black men | Q79291386 | ||
| A meta-analysis of diabetes mellitus and the risk of prostate cancer | Q79374493 | ||
| P433 | issue | 1 | |
| P921 | main subject | prostate cancer | Q181257 |
| systematic review | Q1504425 | ||
| P304 | page(s) | 58-64 | |
| P577 | publication date | 2009-09-01 | |
| P1433 | published in | Prostate Cancer and Prostatic Diseases | Q2108326 |
| P1476 | title | Does pre-existing diabetes affect prostate cancer prognosis? A systematic review | |
| P478 | volume | 13 |
| Q49486668 | A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus |
| Q35077079 | Addressing the contribution of previously described genetic and epidemiological risk factors associated with increased prostate cancer risk and aggressive disease within men from South Africa |
| Q98158698 | Adipocytes protect fibroblasts from radiation-induced damage by adiponectin secretion |
| Q30242051 | Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing? |
| Q40782810 | Concurrent Diabetes Mellitus may Negatively Influence Clinical Progression and Response to Androgen Deprivation Therapy in Patients with Advanced Prostate Cancer |
| Q38000089 | Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer |
| Q34069053 | Diabetes and cancer I: risk, survival, and implications for screening |
| Q38097984 | Diabetes and cancer relationships |
| Q28072665 | Diabetes and mortality in patients with prostate cancer: a meta-analysis |
| Q36637909 | Diabetes and risk of cancer |
| Q39529518 | Diabetes causes multiple genetic alterations and downregulates expression of DNA repair genes in the prostate |
| Q26864963 | Diabetes mellitus and poorer prognosis in hepatocellular carcinoma: a systematic review and meta-analysis |
| Q38234432 | Diabetes mellitus is associated with elevated risk of mortality amongst patients with prostate cancer: a meta-analysis of 11 cohort studies |
| Q44370016 | Diabetes mellitus is associated with short prostate-specific antigen doubling time after radical prostatectomy |
| Q43478062 | Diabetes predicts metastasis after radical prostatectomy in obese men: results from the SEARCH database |
| Q53085995 | Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma. |
| Q28391921 | Epithelial cancers in the post-genomic era: should we reconsider our lifestyle? |
| Q34450860 | Inflammatory cytokines and survival factors from serum modulate tweak-induced apoptosis in PC-3 prostate cancer cells |
| Q50105959 | Metformin and cancer: An existing drug for cancer prevention and therapy |
| Q35764409 | Metformin: multi-faceted protection against cancer |
| Q94496697 | MnTE-2-PyP, a manganese porphyrin, reduces cytotoxicity caused by irradiation in a diabetic environment through the induction of endogenous antioxidant defenses |
| Q36734036 | New players for advanced prostate cancer and the rationalisation of insulin-sensitising medication |
| Q40111911 | Outcomes of preexisting diabetes mellitus in breast, colorectal, and prostate cancer. |
| Q90055018 | Pre- and Post-diagnosis Diabetes as a Risk Factor for All-Cause and Cancer-Specific Mortality in Breast, Prostate, and Colorectal Cancer Survivors: a Prospective Cohort Study |
| Q36575795 | Preoperative erectile function and the pathologic features of prostate cancer |
| Q36678127 | Quality of care for comorbid conditions during the transition to survivorship: differences between cancer survivors and noncancer controls |
| Q35153493 | Survival of patients with stage IV lung cancer with diabetes treated with metformin |
| Q90529107 | The Effect of Diabetes Mellitus on Prognosis of Patients with Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis |
| Q34510892 | The diabetes-cancer link |
| Q83209166 | The impact of diabetes on survival in women with ovarian cancer |
| Q34113485 | The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies. |
| Q35565610 | Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients. |
| Q90070289 | Trends in cancer mortality among people with vs without diabetes in the USA, 1988-2015 |
| Q38047525 | Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidence. |
Search more.